{"filing":{"accession_number":"0001213900-26-099700","cik":"0001711754","ticker":"INMB","company_name":"Inmune Bio, Inc.","form":"8-K","filing_date":"2026-09-14","report_date":"2026-09-08","primary_document":"ea0305404-8k_inmune.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026099700/ea0305404-8k_inmune.htm"},"events":[{"id":33259,"run_id":30580,"accession_number":"0001213900-26-099700","anchor_item_number":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of two new directors, R. Duane Clark II and James Sapirstein, to INmune Bio's Board of Directors on September 8, 2026. Item 5.02 explicitly covers this appointment, and the prose emphasizes their extensive experience in rare-disease commercialization and business development—capabilities directly aligned with the company's advancement of Ebstrocel toward potential commercialization. This is a material governance event affecting board composition and strategic direction.","company_name":"Inmune Bio, Inc.","ticker":"INMB","filing_date":"2026-09-14","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":36655,"accession_number":"0001213900-26-099700","item_number":null,"item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of two new directors, R. Duane Clark II and James Sapirstein, to INmune Bio's Board of Directors on September 8, 2026. Item 5.02 explicitly covers this appointment, and the prose emphasizes their extensive experience in rare-disease commercialization and business development—capabilities directly aligned with the company's advancement of Ebstrocel toward potential commercialization. This is a material governance event affecting board composition and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T20:08:48.367489+00:00","company_name":"Inmune Bio, Inc.","ticker":"INMB","filing_date":"2026-09-14"}]}